|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,957 JPY | +0.17% |
|
+0.39% | +14.36% |
| Apr. 03 | Sawai Group Finalizes Sale of US Subsidiary | MT |
| Apr. 01 | Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. | CI |
Sawai Pharmaceutical Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2023. For the year, the company expects sales to be JPY 207,000 million. Operating profit to be JPY 21,400 million.
Profit attributable to owners of parent to be JPY 17,700 million. Basic earnings per share to be JPY 404.19.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.36% | 1.66B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
SAWAI GROUP HOLDINGS CO., LTD. 
